Medicine
Glimepiride and Pioglitazone 4 mg/30 mg tablet
Glimepiride and Pioglitazone 4 mg/30 mg tablet is a generic prescription medicine for oral use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F). Keep…
Key facts
- Active ingredient (INN)
- Glimepiride and Pioglitazone
- Brand
- Sold under the generic name
- Strength
- 4 mg/30 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets
- Manufacturer
- Prasco Laboratories
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F). Keep container tightly closed and protect from moisture and humidity.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A10BD06 Glimepiride and Pioglitazone
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 4 August 2015
- Identifiers
- RxCUI 647237, 647239DailyMed set ID ea385b3d-cb4c-4550-97b0-93a86533f6dcNDC 66993-822Application NDA021925
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet in 1 bottle | 66993-822-30 | Prasco Laboratories | 4 August 2015 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Glimepiride and Pioglitazone 4 mg/30 mg tablet.
Other strengths and forms of Glimepiride and Pioglitazone
Clinical summary
Glimepiride and Pioglitazone is a fixed-dose combination of a peroxisome proliferator receptor alpha agonist, a peroxisome proliferator receptor gamma agonist and a sulfonylurea. It is available as tablets for oral use. MedsAcross supplies Glimepiride and Pioglitazone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Glimepiride and PioglitazoneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- pioglitazone and glimepiride prescribing information (Prasco Laboratories) · U.S. National Library of Medicine, DailyMed
- Tandemact: European public assessment report (EPAR) · European Medicines Agency
Need Glimepiride and Pioglitazone 4 mg/30 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.